Zhengye Biotechnology Holding Limited (ZYBT)

ZYBT Cash Flow Statement

Financials in millions CNY. Fiscal year is January - December.

Year Ending	TTM	Dec 31, 2022	Dec 31, 2021
Net Income	52.26	46.74	38.96
Depreciation & Amortization	-	18.8	16.01
Other Operating Activities	-35.34	-57.21	-30.67
Operating Cash Flow	16.92	17.34	31.81
Operating Cash Flow Growth	-	-45.50%	-
Other Investing Activities	-	-27.33	-26.27
Investing Cash Flow	-8	-27.33	-26.27
Dividends Paid	-	-27.33	-26.4
Debt Issued / Paid	-	34.88	8
Other Financing Activities	-11.18	5.9	15.35
Financing Cash Flow	-11.18	13.46	-3.05
Net Cash Flow	-2.26	3.46	2.49
Free Cash Flow	8.93	-9.99	5.41
Free Cash Flow Margin	3.52%	-3.84%	2.53%

Source: IPO financials are sourced from S-1 and S-1/A filings submitted to the Securities and Exchange Commission (SEC).